3B Blackbio DX Share Price

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of Indias leading agrobusiness companies. Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023.The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the TRUPCR brand, alongside developing NextGen Sequencing (NGS) assays (TRUNGS) Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bioproducts), serving both labs and government sectors, driven by RD for innovative solutions. The Company has representation in India in the field of agriculture business comprising crop protection, public health products and bioproducts and is reputed reliable supplier to various Govt. organizations, such as Directorate General of Supplies Transport, New Delhi, NAVY, Vishakapatnam/Mumbai, Food Corporation of India Raipur/ Bhopal/ Lucknow/ Mumbai/ Jaipur, NTPC, Bilaspur, Directorate of Health Service, M.P/Maharashtra/AP, Directorate of General Of Health Organization, Gujarat/U.P, Directorate General of Health services, MOHFW (NVBDCP), Govt. of India, M/s Hindustan Latex Ltd, Noida, Director of Agriculture and Horticulture, M.P./Trivandrum, Central/Western Railway, Mumbai, Northern Railway, New Delhi etc. the company has nationwide distribution network of over 2000 dealers.It possess well equipped RD laboratory duly approved and recognized by DSIR, Ministry of Science and Technology, Government of India. Advanced instrumentation facility supported by equally competent team of scientists and technicians lay down a strong RD foundation. Clean and hygienic environment ensure the consistency and reliability of results. Laboratory studies are planned, performed, monitored, recorded, applied in small scale field and then tabulated.The products are manufactured to high International specifications with stringent quality control from raw material procurement to finished goods dispatch. The companys manufacturing process is complimented with the technical expertise and it has attained high standard suited to customer needs on 2372002. Kilpest has received accreditation of International standard ISO 90012000 certified company. The companyhas diversified manufacturing in the field of micronutrients, bioproducts and plant growth regulators etc. The company is also exporting its products to Bangladesh and Afghanistan.In 201112, the Company launched Novel Biotech IndoSpanish Joint Venture Project in Govindpura, Bhopal, Madhya Pradesh. It ventured into Diagnostic Service. In June, 2020, the Company launched , its single tube multiplex assay for TRUPCR SARSCoV2 RTqPCR Kit (RealTime PCR based detection of SARSCoV2 virus) Version 3.2. With this, 3B BlackBio Biotech India Ltd. became first ever Indian molecular diagnostics company to receive US FDA(EUA).Company launched NGS based TRUNGSr Solid Tumor Panel for detection of SNVs, Indels, CNVs and RNA fusions in 35 marker genes and hotspots in 6 pharmocogenomics genes associated with solid tumors such as lung, gastrointestinal/colorectal, breast, liver and ovarian tumors in FY 2024.The Rapid Kit manufacturing facility is made operational in 2025. The Company has added some novel products in Rapid Kit vertical for detection of Antimicrobial Resistance (AMR) genes. The Company has acquired Coris BioConcept SRL, Belgium in FY25.

For the full year FY2026–2027, revenue reached ₹167.48 crore and profit touched at ₹59.93 crore.